- Home
- Publications
- Publication Search
- Publication Details
Title
What’s in the pipeline for the treatment of Parkinson’s disease?
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 8, Issue 12, Pages 1829-1839
Publisher
Informa UK Limited
Online
2008-12-17
DOI
10.1586/14737175.8.12.1829
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease
- (2010) S. Crotty et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Effects of Nebicapone on Levodopa Pharmacokinetics, Catechol-O-methyltransferase Activity, and Motor Fluctuations in Patients with Parkinson Disease
- (2009) Joaquim J. Ferreira et al. CLINICAL NEUROPHARMACOLOGY
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations
- (2008) Olivier Rascol ARCHIVES OF NEUROLOGY
- L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension
- (2008) Christopher J. Mathias CLINICAL AUTONOMIC RESEARCH
- A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease
- (2008) CLINICAL NEUROPHARMACOLOGY
- Is the Deficiency of Vitamin B12 Related to Oxidative Stress and Neurotoxicity in Parkinsons Patients?
- (2008) G. Qureshi et al. CNS & Neurological Disorders-Drug Targets
- Dopamine agonists in Parkinson’s disease
- (2008) Mitsutoshi Yamamoto et al. Expert Review of Neurotherapeutics
- PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson’s disease
- (2008) Naomi P. Visanji et al. FASEB JOURNAL
- Invited Article: Changing concepts in Parkinson disease: Moving beyond the Decade of the Brain
- (2008) C. Marras et al. NEUROLOGY
- Dementia and survival in Parkinson disease: A 12-year population study
- (2008) T. C. Buter et al. NEUROLOGY
- A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
- (2008) M. Stacy et al. NEUROLOGY
- Recent advances in cell-based therapy for Parkinson disease
- (2008) Arnar Astradsson et al. Neurosurgical Focus
- Motor cortex stimulation for pain and movement disorders
- (2008) Jeffrey E. Arle et al. Neurotherapeutics
- Protection against Parkinson’s disease progression: Clinical experience
- (2008) Peter A. LeWitt et al. Neurotherapeutics
- Treatment of Parkinson’s disease with trophic factors
- (2008) Amie L. Peterson et al. Neurotherapeutics
- Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
- (2007) Olle Lindvall et al. EXPERIMENTAL NEUROLOGY
- Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation
- (2007) Masato Asanuma et al. NEUROSCIENCE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now